BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 31691015)

  • 41. Scoring system for the prediction of the severity of placenta accrete spectrum in women with placenta previa: a prospective observational study.
    Luo L; Sun Q; Ying D; Wu X; Yan P; Yang Y; Chen Z
    Arch Gynecol Obstet; 2019 Sep; 300(3):783-791. PubMed ID: 31250197
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Placenta accreta spectrum: We can do better.
    Silveira C; Kirby A; Melov SJ; Nayyar R
    Aust N Z J Obstet Gynaecol; 2022 Jun; 62(3):376-382. PubMed ID: 34984671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical risk factors for placenta previa-placenta accreta.
    Miller DA; Chollet JA; Goodwin TM
    Am J Obstet Gynecol; 1997 Jul; 177(1):210-4. PubMed ID: 9240608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Placenta previa increta/percreta in Japan: a retrospective study of ultrasound findings, management and clinical course.
    Sumigama S; Itakura A; Ota T; Okada M; Kotani T; Hayakawa H; Yoshida K; Ishikawa K; Hayashi K; Kurauchi O; Yamada S; Nakamura H; Matsusawa K; Sakakibara K; Ito M; Kawai M; Kikkawa F
    J Obstet Gynaecol Res; 2007 Oct; 33(5):606-11. PubMed ID: 17845316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prenatal ultrasound staging system for placenta accreta spectrum disorders.
    Cali G; Forlani F; Lees C; Timor-Tritsch I; Palacios-Jaraquemada J; Dall'Asta A; Bhide A; Flacco ME; Manzoli L; Labate F; Perino A; Scambia G; D'Antonio F
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):752-760. PubMed ID: 30834661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interactions between ultrasonographic cervical length and placenta accreta spectrum on severe postpartum hemorrhage in women with placenta previa.
    Dang X; Fan C; Cui F; He Y; Sun G; Ruan J; Fan Y; Lin X; Wu J; Liu Y; Wang S; Bao Y; Xu J; Du H; Chen S; Deng D; Qiao F; Zeng W; Feng L; Liu H
    Int J Gynaecol Obstet; 2023 Jun; 161(3):1069-1074. PubMed ID: 36572390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors and clinical outcomes for placenta accreta spectrum with or without placenta previa.
    Ogawa K; Jwa SC; Morisaki N; Sago H
    Arch Gynecol Obstet; 2022 Mar; 305(3):607-615. PubMed ID: 34448037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of contingent screening for placenta accreta spectrum disorders based on persistent low-lying placenta and previous uterine surgery.
    Coutinho CM; Giorgione V; Noel L; Liu B; Chandraharan E; Pryce J; Frick AP; Thilaganathan B; Bhide A
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):91-96. PubMed ID: 32865834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A retrospective analysis of pathological placental implantation--site and penetration.
    Makhseed M; el-Tomi N; Moussa M
    Int J Gynaecol Obstet; 1994 Nov; 47(2):127-34. PubMed ID: 7843481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta.
    Marcellin L; Delorme P; Bonnet MP; Grange G; Kayem G; Tsatsaris V; Goffinet F
    Am J Obstet Gynecol; 2018 Aug; 219(2):193.e1-193.e9. PubMed ID: 29733839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intraoperative aorta balloon occlusion: fertility preservation in patients with placenta previa accreta/increta.
    Panici PB; Anceschi M; Borgia ML; Bresadola L; Masselli G; Parasassi T; Perrone G; ; Brunelli R
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2512-6. PubMed ID: 22992070
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The relation between maternal obesity and placenta accreta spectrum: A multinational database study.
    Vieira MC; Rijken MJ; Braun T; Chantraine F; Morel O; Schwickert A; Stefanovic V; van Beekhuizen H; Collins SL;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1():50-57. PubMed ID: 33811335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Value of ultrasound scoring system for assessing risk of pernicious placenta previa with accreta spectrum disorders and poor pregnancy outcomes.
    Zhu L; Xie L
    J Med Ultrason (2001); 2019 Oct; 46(4):481-487. PubMed ID: 31392444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prophylactic radiologic interventions to reduce postpartum hemorrhage in women with risk factors for placenta accreta spectrum disorder: a nationwide cohort study.
    Bonsen LR; Harskamp V; Feddouli S; Bloemenkamp KWM; Duvekot JJ; Pors A; van Roosmalen J; Zwart JJ; van Lith JMM; Hendriks J; Urlings TAJ; van den Akker T; van der Bom JG; Henriquez DDCA;
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2251076. PubMed ID: 37673791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A 5-year experience on perinatal outcome of placenta accreta spectrum disorder managed by cesarean hysterectomy in southern Iranian women.
    Kasraeian M; Hashemi A; Hessami K; Alamdarloo SM; Vahdani R; Vafaei H; Najib FS; Shiravani Z; Razavi B; Homayoon N; Nayebi M; Bazrafshan K; Jahromi MA
    BMC Womens Health; 2021 Jun; 21(1):243. PubMed ID: 34130685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prior placenta accreta is an independent risk factor for post-partum hemorrhage in subsequent gestations.
    Vinograd A; Wainstock T; Mazor M; Mastrolia SA; Beer-Weisel R; Klaitman V; Dukler D; Hamou B; Benshalom-Tirosh N; Vinograd O; Erez O
    Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():20-4. PubMed ID: 25681995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Placenta accreta and maternal morbidity in the Republic of Ireland, 2005-2010.
    Upson K; Silver RM; Greene R; Lutomski J; Holt VL
    J Matern Fetal Neonatal Med; 2014 Jan; 27(1):24-9. PubMed ID: 23638753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical significance of retained products of conception in placenta previa: a retrospective analysis.
    Kishimoto N; Miyamoto M; Imauji A; Takada M; Nishitani S; Tanabe R; Ito T; Hada T; Otsuka Y; Takano M
    BMC Pregnancy Childbirth; 2023 Jun; 23(1):481. PubMed ID: 37391723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro fertilization as an independent risk factor for placenta accreta spectrum.
    Salmanian B; Fox KA; Arian SE; Erfani H; Clark SL; Aagaard KM; Detlefs SE; Aalipour S; Espinoza J; Nassr AA; Gibbons WE; Shamshirsaz AA; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2020 Oct; 223(4):568.e1-568.e5. PubMed ID: 32360847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes of Subsequent Births After Placenta Accreta Spectrum.
    Baldwin HJ; Nippita TA; Torvaldsen S; Ibiebele I; Ford JB; Patterson JA
    Obstet Gynecol; 2020 Oct; 136(4):745-755. PubMed ID: 32925617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.